Jan 6 (Reuters) - Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic data to discover new drug candidates to send into human ...
BA.3.2, a heavily mutated new COVID-19 variant that may be better able to evade immunity from vaccines or prior infection, is now spreading in the United States. Although COVID infections are...
A new variant of the virus that causes COVID is spreading in the U.S. The “Cicada” variant, officially known as BA.3.2, was first detected in South Africa in November 2024.
The Centers for Disease Control and Prevention and the World Health Organization are both monitoring a COVID-19 variant called BA.3.2, which is nicknamed "Cicada."
New variants of SARS-CoV-2 are expected to continue to emerge. Some variants will emerge and disappear, while others will emerge and continue to spread and may replace previous variants.
While COVID-19 cases are down overall nationwide, the Cicada variant is quickly gaining ground, new data shows.
New 'Cicada' COVID variant rapidly rising in the US. What is it?
Public health experts use various methods of surveillance to track variants, including testing samples of wastewater, collecting voluntary nasal swabs from travelers, and reviewing viral samples...
A new highly mutated COVID‑19 variant, officially designated BA.3.2 and nicknamed “Cicada,” is being monitored closely by health officials as it spreads across the United States and other ...
Highly mutated COVID variant Cicada is on the rise in ... - MSN
Yahoo: Variant Bio launches AI-powered platform for drug discovery using genetic data